{
  "filename": "77---A-51-Year-Old-Female-Traveller-Returning-from-Cen_2022_Clinical-Cases-i.pdf",
  "markdown_path": "./Processed/markdown/77---A-51-Year-Old-Female-Traveller-Returning-from-Cen_2022_Clinical-Cases-i.md",
  "images": [
    {
      "page": 1,
      "path": "./Processed/images/77---A-51-Year-Old-Female-Traveller-Returning-from-Cen_2022_Clinical-Cases-i/77---A-51-Year-Old-Female-Traveller-Returning-from-Cen_2022_Clinical-Cases-i_p1_img1.jpeg"
    },
    {
      "page": 2,
      "path": "./Processed/images/77---A-51-Year-Old-Female-Traveller-Returning-from-Cen_2022_Clinical-Cases-i/77---A-51-Year-Old-Female-Traveller-Returning-from-Cen_2022_Clinical-Cases-i_p2_img1.jpeg"
    }
  ],
  "table_text": "TABLE 77.1 Comparative Clinical Symptom Patterns Observed in Dengue, Chikungunya and Zika Infections.\n| Symptom / Feature         | Dengue | Chikungunya | Zika |\n|---------------------------|--------|-------------|------|\n| Incubation period (days)  | 4-10   | 3-7         | 3-12 |\n| Asymptomatic infection (%)| 50-80  | 3-28        | 80   |\n| Fever                     | +++    | +++         | +    |\n| Headache                  | +++    | ++          | +    |\n| Conjunctivitis            | -      | -           | ++   |\n| Arthralgias               | ++     | +++         | +    |\n| Myalgias                  | ++     | +           | +    |\n| Skin rash                 | ++     | ++          | +++  |\n| Peripheral oedema         | -      | -           | ++   |\n| Haemorrhagic manifestations| ++     | (+)         | -    |\n| Circulatory collapse/ shock| +      | -           | -    |\n| Thrombocytopenia          | ++     | ++          | -    |\n| Lymphadenopathy           | ++     | ++          | +    |\n\nTABLE 77.2 Blood Test Results\n| Test                 | First serum sample† | Second serum sample‡ | Interpretation   |\n|----------------------|---------------------|----------------------|------------------|\n| Dengue IgM IIFT      | negative            | negative             | negative         |\n| Dengue IgG IIFT      | 1:20                | 1:5120               | cross-reactivity |\n| Dengue NS1-Ag        | negative            | negative             | negative         |\n| Chikungunya IgM ELISA| negative            | ND                   | negative         |\n| Chikungunya IgM IIFT | ND                  | negative             | negative         |\n| Chikungunya IgG IIFT | ND                  | negative             | negative         |\n| Zika IgM IIFT        | negative            | 1:640                | positive         |\n| Zika IgG IIFT        | 1:20                | 1:5120               | positive         |\n| Zika RT-PCR          | positive            | ND                   | positive         |\n†obtained 6 days after onset of symptoms\n‡obtained 7 days after the first serum sample\nIIFT: Indirect Immunofluorescence Test; RT-PCR: real-time reverse transcription polymerase chain reaction; ELISA: Enzyme-linked Immunosorbent Assay; ND: not done.",
  "table_source": "/Users/macintoshhd/Downloads/Project-Dr.Khanh/Clinical-RAG/Processed/out_all_structured/77---A-51-Year-Old-Female-Traveller-Returning-from-Cen_2022_Clinical-Cases-i-tables.md",
  "table_label": "TABLE 77.1",
  "table_caption": "Comparative Clinical Symptom Patterns Observed in Dengue, Chikungunya and Zika Infections."
}